Stage FocusSeed, Series A, Series B+
GeographyUS, Europe
TypeCVC
Last Activity2025
Industry Focus
Industries
BiotechMedTech
Technical BenchStrong
Investor TypeCVC
ExposureMostly DeepTech Investments
Bio
Sanofi Ventures is the CVC arm of Sanofi, a top-5 global pharmaceutical company. The fund now exceeds $1.4B in AUM after a $625M addition in September 2025. Since inception in 2012, the firm has deployed $800M+ across 70+ innovative biotech and digital health companies.
Focus areas align with Sanofi's strategic priorities: immunology, rare diseases, neurology, and vaccines. The exit track record ...
Notable Investments
I
IcosavaxA
Aliada TherapeuticsE
Escient PharmaceuticalsSimilar Funds
Novartis Venture Fund
Basel, Switzerland
GeneralistBiotechMedTechSeedSeries A
Pfizer Ventures
New York, United States
GeneralistBiotechMedTechSeedSeries A
Roche Venture Fund
Basel, Switzerland
GeneralistBiotechMedTechSeedSeries A
Abingworth
London, United Kingdom
DeepTech NativeBiotechMedTechSeedSeries A
Brandon Capital
Melbourne, Australia
DeepTech NativeBiotechMedTechSeedSeries A
Leaps by Bayer
Leverkusen, Germany
DeepTech NativeBiotechAgriTechMedTechSeedSeries A